Royalty Pharma
Greg Norden is the former Chief Financial Officer of Wyeth. Mr. Norden also serves on the Boards of Zoetis, the leading animal health company; NanoString, a leading provider of life science tools for translational medicine; and Praxis, a clinical-stage biopharmaceutical company. Mr. Norden is a former director of Human Genome Sciences, Univision, and Welch Allyn. In addition, Mr. Norden is the Managing Director of G9 Capital Group, LLC, which invests in early-stage ventures and provides corporate advisory services. Mr. Norden has a B.S. in Management and Economics from the State University of New York at Plattsburgh and an M.S. in Accounting from LIU Post.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Royalty Pharma
3 followers
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals, and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies.